Fig-1 (Gabapentin Fig1)
The text is not-readable.*
Gabapentin Capsule
Product Images NDC 71335-2700
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-2700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Gabapentin Fig2)
This appears to be a chart showing mean pain scores for a study evaluating the effects of two treatments, placebo and gabapentin at a dosage of 3600 mg/day, over a period of several weeks. The mean pain scores suggest the effectiveness of each treatment in reducing pain levels.*
Figure 2 (Gabapentin Fig3)
This text appears to mention "Mean Pain Score" and different doses of Gabapentin (1800 mg/day and 2400 mg/day) in relation to a study period of fewer than 3 weeks and a fixed dose period of 4 weeks. The study likely involves assessing pain relief or management.*
Figure 3 (Gabapentin Fig4)
This text is describing the proportion of responders (patients with greater than or equal to a 50% reduction in pain score) in controlled studies on Postherpetic Neuralgia (PHN). The data is presented in percentages for two study groups, Study 1 and Study 2. The values indicate the percentage of responders in each group based on different treatment regimens. The text also includes statistical markers (#p<001, 5D < 0.001) and mentions the treatment groups PBO (Placebo), GBP 3600 (Gabapentin 3600mg), PBO GBP 1800 (Placebo then Gabapentin 1800mg), and GBP 2400 (Gabapentin 2400mg).*
Fig-5 (Gabapentin Fig5)
Chemical Structure (Gabapentin Str)
Label (Lbl713352700)
This is a description of Gabapentin capsules. Each capsule contains 400 mg of Gabapentin, USP. The capsules are stored at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). It is recommended to keep them in a tight, child-resistant container and out of the reach of children. The medication may cause dizziness. Dispense only with a prescription and follow the dosage and usage instructions provided in the package insert. The capsules are repackaged by Bryant Ranch Prepack, Inc. and manufactured by Aurobindo Pharma Limited.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
